FDAnews Device Daily Bulletin

ORSENSE'S NON-INVASIVE CONTINUOUS GLUCOSE MONITORING SYSTEM ACHIEVES ACCURATE PERFORMANCE IN HOME USE SETTING

June 13, 2006
A A

Results Presented at the Scientific Session of the 66th American Diabetes Association (ADA) Show Median Relative Absolute Difference of 12.9% in a Wide Range of Glucose Levels. Results of a study by a group of clinicians at the Chaim Sheba Medical Center, presented at the 66th Scientific Session of the American Diabetes Association (ADA) taking place June 9-13, 2006 in Washington, D.C., indicate that the NBM-100G, a non-invasive continuous glucose monitoring sensor developed by OrSense Ltd., accurately measures levels of glucose in a home like setting.
Genetic Engineering News